Identify the diagnostic challenges and pathophysiological considerations of preeclampsia. |
|
|
|
|
|
Apply evidence-based guidelines for the use of magnesium sulfate in the management of preeclampsia, including appropriate dosing strategies for patients with severe features, renal disease and myasthenia gravis. |
|
|
|
|
|
Implement a comprehensive approach to managing critically ill preeclamptic patients. |
|
|
|
|
|
Apply current screening recommendations prior to 20 weeks of gestation. |
|
|
|
|
|
Utilize ultrasound and antenatal testing surveillance stratified by maternal age (AMA, extreme AMA) and those requiring in vitro fertilization (IVF). |
|
|
|
|
|
Address special clinical scenarios for aging gravidas. |
|
|
|
|
|